FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称PAXALISIB
异名/同义词2-PYRIMIDINAMINE, 5-(8,9-DIHYDRO-6,6-DIMETHYL-4-(4-MORPHOLINYL)-6H-(1,4)OXAZINO(4,3-E)PURIN-2-YL)-
5-(6,6-DIMETHYL-4-MORPHOLINO-8,9-DIHYDRO-6H-(1,4)OXAZINO(3,4-E)PURIN-2-YL)PYRIMIDIN-2-AMINE
G02441729
G-02441729
GDC0084
GDC-0084
PAXALISIB
PAXALISIB [INN]
PAXALISIB [USAN]
PAXALISIB [WHO-DD]
RG 7666
RG-7666
SIM-0395
CAS登记号1382979-44-3
物质唯一标识(Unique Ingredient Identifier)P5DKZ70636
分子式C18H22N8O2
国际化合物标识(International Chemical Identifier,InChI)LGWACEZVCMBSKW-UHFFFAOYSA-N
SMILESC1CN(c2nc(-c3cnc(N)nc3)nc4c2nc5C(C)(C)OCCn45)CCO1
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System